Skip to content

Drug interactions

Bosentan + Enzalutamide

Severity: Moderate

Bosentan and Enzalutamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide is a strong CYP3A4 and CYP2C9 inducer and can lower bosentan exposure, which may reduce efficacy in pulmonary arterial hypertension. Bosentan, a moderate inducer, may also modestly lower enzalutamide levels.

What this interaction means in plain words

Bosentan and Enzalutamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosentan belongs to Miscellaneous; Enzalutamide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Enzalutamide induces CYP3A4 and CYP2C9, increasing bosentan metabolism; bosentan weakly induces CYP3A4.

What to do

Monitor PAH clinical response and consider alternative therapy if efficacy falls; also monitor liver function, as bosentan is hepatotoxic.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Enzalutamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Enzalutamide?

MediHelp rates the interaction as moderate. Bosentan and Enzalutamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Enzalutamide is a strong CYP3A4 and CYP2C9 inducer and can lower bosentan exposure, which may reduce efficacy in pulmonary arterial hypertension. Bosentan, a moderate inducer, may also modestly lower enzalutamide levels.

How serious is the interaction between Bosentan and Enzalutamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor PAH clinical response and consider alternative therapy if efficacy falls; also monitor liver function, as bosentan is hepatotoxic.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in